TrialEmerging microbes & infections2022

Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study.

Rujipas Sirijatuphat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.